Specifica, an IQVIA business, specializes in creating exceptional antibody libraries. Its patented Generation 3 antibody discovery platform delivers developable, high-affinity antibodies directly from selections – minimizing the need for downstream affinity and biophysical engineering. In addition to building and transferring exclusive libraires, Specifica executes discovery campaigns for customers at its lab in Santa Fe, New Mexico.